|
|
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.JP |
First Approval Date26 Oct 2009 |
Target- |
MechanismUltrasonography enhancers |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. |
First Approval Date01 Jan 1996 |
|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Tanabe Seiyaku Co., Ltd. /Pet Medicine Operations/
0 Patents (Medical) associated with Tanabe Seiyaku Co., Ltd. /Pet Medicine Operations/
100 Deals associated with Tanabe Seiyaku Co., Ltd. /Pet Medicine Operations/
100 Translational Medicine associated with Tanabe Seiyaku Co., Ltd. /Pet Medicine Operations/